Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation
Jongshin Kim, Yoo Hyung Kim, Jaeryung Kim, Do Young Park, Hosung Bae, Da-Hye Lee, Kyun Hoo Kim, Seon Pyo Hong, Seung Pil Jang, Yoshiaki Kubota, Young-Guen Kwon, Dae-Sik Lim, Gou Young Koh
Jongshin Kim, Yoo Hyung Kim, Jaeryung Kim, Do Young Park, Hosung Bae, Da-Hye Lee, Kyun Hoo Kim, Seon Pyo Hong, Seung Pil Jang, Yoshiaki Kubota, Young-Guen Kwon, Dae-Sik Lim, Gou Young Koh
View: Text | PDF
Research Article Angiogenesis Development

YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation

  • Text
  • PDF
Abstract

Angiogenesis is a multistep process that requires coordinated migration, proliferation, and junction formation of vascular endothelial cells (ECs) to form new vessel branches in response to growth stimuli. Major intracellular signaling pathways that regulate angiogenesis have been well elucidated, but key transcriptional regulators that mediate these signaling pathways and control EC behaviors are only beginning to be understood. Here, we show that YAP/TAZ, a transcriptional coactivator that acts as an end effector of Hippo signaling, is critical for sprouting angiogenesis and vascular barrier formation and maturation. In mice, endothelial-specific deletion of Yap/Taz led to blunted-end, aneurysm-like tip ECs with fewer and dysmorphic filopodia at the vascular front, a hyper-pruned vascular network, reduced and disarranged distributions of tight and adherens junction proteins, disrupted barrier integrity, subsequent hemorrhage in growing retina and brain vessels, and reduced pathological choroidal neovascularization. Mechanistically, YAP/TAZ activates actin cytoskeleton remodeling, an important component of filopodia formation and junction assembly. Moreover, YAP/TAZ coordinates EC proliferation and metabolic activity by upregulating MYC signaling. Overall, these results show that YAP/TAZ plays multifaceted roles for EC behaviors, proliferation, junction assembly, and metabolism in sprouting angiogenesis and barrier formation and maturation and could be a potential therapeutic target for treating neovascular diseases.

Authors

Jongshin Kim, Yoo Hyung Kim, Jaeryung Kim, Do Young Park, Hosung Bae, Da-Hye Lee, Kyun Hoo Kim, Seon Pyo Hong, Seung Pil Jang, Yoshiaki Kubota, Young-Guen Kwon, Dae-Sik Lim, Gou Young Koh

×

Figure 9

YAP/TAZ depletion impairs EC migration and filopodia/lamellipodia formation by suppressing CDC42 and MLC2 activity.

Options: View larger image (or click on image) Download as PowerPoint
YAP/TAZ depletion impairs EC migration and filopodia/lamellipodia format...
(A and B) Images and comparison of wound healing migration in HUVECs transfected with siCont (siCont-ECs) or siYAP/TAZ (siYAP/TAZ-ECs) (n = 4, each group). Scale bars: 500 μm. (C and D) Images of phalloidin+ actin cytoskeleton and comparisons of indicated parameters in siCont-ECs and siYAP/TAZ-ECs after VEGF stimulation for 30 minutes (n = 4, each group). Scale bars: 20 μm. (E) Immunoblot analyses of indicated proteins in siCont-ECs and siYAP/TAZ-ECs stimulated with VEGF for indicated times. Similar findings were observed in 3 independent experiments. (F) Comparisons of activities of RhoA, Rac1, and CDC42 in siCont-ECs and siYAP/TAZ-ECs stimulated with VEGF for 30 minutes (n = 4, each group). Note that siYAP/TAZ-ECs show markedly attenuated CDC42 activity. (G and H) Immunoblot analyses and comparisons of indicated proteins in siCont-ECs and siYAP/TAZ-ECs (n = 3, each group). Note that siYAP/TAZ-ECs show selectively reduced protein level of CDC42. (I) Immunoblot analyses and comparisons of indicated proteins in siCont-ECs and siYAP/TAZ-ECs (siY/T) (n = 3–4, each group). Numbers indicate mean ± SD. Note that siYAP/TAZ-ECs show significantly reduced MLC2, a key regulator of contractile force. (J and K) Images and comparison of pMLC2 (at Ser19) in CD31+ retinal vessels at P5 in WT and Yap/TaziΔEC mice (n = 4, each group). Scale bars: 100 μm. (L) GSEA of isolated brain ECs showing downregulated GO term “regulation of actin filament based movement” in Yap/TaziΔEC mice compared with WT mice. ES, enrichment score; NES, normalized enrichment score. Error bars represent mean ± SD. *P < 0.05 vs. siCont or WT mice by Mann-Whitney U test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts